Volume 3, Issue 9, Pages e421-e430 (September 2016)

Slides:

Advertisements

Similar presentations

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants The Lancet Volume 387, Issue 10027,

Advertisements

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials The Lancet Volume 386, Issue.

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta- analysis of the randomised trials The Lancet Volume 386, Issue 10001,

Volume 390, Issue 10101, Pages (September 2017)

Volume 380, Issue 9846, Pages (September 2012)

Volume 2, Issue 1, Pages e12-e19 (January 2015)

Volume 386, Issue 9988, Pages (July 2015)

Volume 383, Issue 9928, Pages (May 2014)

Volume 385, Issue 9985, Pages (June 2015)

Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary.

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort.

Effect of a bereavement support group on female adolescents' psychological health: a randomised controlled trial in South Africa Prof Tonya Renee Thurman,

Volume 386, Issue 9992, Pages (August 2015)

Volume 376, Issue 9734, Pages (July 2010)

Volume 2, Issue 4, Pages e151-e158 (April 2015)

Self-assessment of the outcome of early medical abortion versus clinic follow-up in India: a randomised, controlled, non-inferiority trial Dr Kirti Iyengar,

Paediatric HIV-1 infection

Volume 5, Issue 4, Pages (April 2006)

Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary.

Volume 389, Issue 10076, Pages (April 2017)

Volume 376, Issue 9734, Pages (July 2010)

Statins and type 2 diabetes: genetic studies on target

Estimating trends in life expectancy in HIV-positive individuals

Volume 5, Issue 2, Pages e79-e86 (February 2018)

Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses

Volume 382, Issue 9891, Pages (August 2013)

Volume 14, Issue 4, Pages (April 2015)

Effects of community health interventions on under-5 mortality in rural Guinea-Bissau (EPICS): a cluster-randomised controlled trial Dr Peter Boone,

Sexual health: a post-2015 palimpsest in global health?

WHO's new guidelines for antiretroviral treatment

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

Volume 386, Issue 9999, Pages (September 2015)

AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised,

Self-assessment of the outcome of early medical abortion versus clinic follow-up in India: a randomised, controlled, non-inferiority trial Dr Kirti Iyengar,

Socioeconomic differences in mortality in the antiretroviral therapy era in Agincourt, rural South Africa, 2001–13: a population surveillance analysis

Volume 381, Issue 9875, Pages (April 2013)

Socioeconomic differences in mortality in the antiretroviral therapy era in Agincourt, rural South Africa, 2001–13: a population surveillance analysis

Adrian Martineau The Lancet Respiratory Medicine

Volume 382, Issue 9900, Pages (October 2013)

Volume 386, Issue 10001, Pages (October 2015)

Volume 14, Issue 9, Pages (September 2015)

Volume 384, Issue 9938, Pages (July 2014)

Volume 386, Issue 9992, Pages (August 2015)

Volume 385, Issue 9985, Pages (June 2015)

Volume 375, Issue 9709, Pages (January 2010)

Effect of a bereavement support group on female adolescents' psychological health: a randomised controlled trial in South Africa Prof Tonya Renee Thurman,

Volume 393, Issue 10180, Pages (April 2019)

Volume 371, Issue 9627, Pages (May 2008)

Volume 5, Issue 1, Pages e35-e44 (January 2018)

Volume 2, Issue 10, Pages e417-e426 (October 2015)

Volume 15, Issue 6, Pages (May 2014)

Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models Daniel Keebler,

Volume 385, Issue 9968, Pages (February 2015)

Volume 383, Issue 9928, Pages (May 2014)

Volume 375, Issue 9719, Pages (March 2010)

Tuberculosis case detection by trained inmate peer educators in a resource-limited prison setting in Ethiopia: a cluster-randomised trial Kelemework.

Volume 13, Issue 12, Pages (December 2014)

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled.

Volume 12, Issue 8, Pages (August 2013)

Thank you to our diverse (but not diverse enough) reviewers

Effect of standard dose paracetamol versus placebo as antipyretic therapy on liver injury in adult dengue infection: a multicentre randomised controlled.

ACST: which subgroups will benefit most from carotid endarterectomy?

Volume 373, Issue 9672, Pages (April 2009)

Volume 6, Pages (December 2018)

Volume 14, Issue 9, Pages (September 2015)

Costs of eliminating HIV in South Africa have been underestimated

Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational,

Recurrence after low-dose radioiodine ablation and recombinant human thyroid- stimulating hormone for differentiated thyroid cancer (HiLo): long-term results.

Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,

A probiotic trial: tipping the balance of evidence?

Presentation transcript:

Volume 3, Issue 9, Pages e421-e430 (September 2016) Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial The Lancet HIV Volume 3, Issue 9, Pages e421-e430 (September 2016) DOI: 10.1016/S2352-3018(16)30054-6 Copyright © 2016 The BREATHER (PENTA 16) Trial Group. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 1 Trial profile *One participant was unable to attend the randomisation visit due to a traffic accident and another participant was excluded because of unreliable attendance. The Lancet HIV 2016 3, e421-e430DOI: (10.1016/S2352-3018(16)30054-6) Copyright © 2016 The BREATHER (PENTA 16) Trial Group. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 2 Time to viral rebound (A) Kaplan-Meier graph adjusted for stratification factors—time from randomisation to viral rebound (confirmed viral load ≥50 copies per mL). (B) Estimated difference in proportion of participants with viral rebound (two-sided 90% CI) between short cycle therapy and continuous therapy at week 48 for different analyses. *Difference in estimated probability of viral rebound, Kaplan-Meier methods, with adjustment for study stratification factors. †Difference in estimated probability of viral rebound, Kaplan-Meier methods. ‡With exact confidence intervals. §Kaplan-Meier methods, censoring individuals who violated the profile at that time, with adjustment for study stratification factors. The Lancet HIV 2016 3, e421-e430DOI: (10.1016/S2352-3018(16)30054-6) Copyright © 2016 The BREATHER (PENTA 16) Trial Group. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 3 Proportion of days MEMS caps were opened Data for 31 participants in the short cycle therapy group and 30 participants in the continuous treatment group (including 23 in each group with data to 48 weeks). MEMS=Medication Event Monitoring System. The Lancet HIV 2016 3, e421-e430DOI: (10.1016/S2352-3018(16)30054-6) Copyright © 2016 The BREATHER (PENTA 16) Trial Group. Open Access article distributed under the terms of CC BY Terms and Conditions